Changshan Yang

发表

Original Article Gambogic acid moderates cardiac responses to chronic hypoxia likely by acting on the proteasome and NF-κB pathway

Jinbao Liu, Xiaofen Li, Xuejun Wang, 2013 .

Gambogic acid moderates cardiac responses to chronic hypoxia likely by acting on the proteasome and NF-κB pathway.

Jinbao Liu, Xiaofen Li, Xuejun Wang, 2013, American journal of cardiovascular disease.

Gambogic acid suppresses pressure overload cardiac hypertrophy in rats.

Jinbao Liu, Xiaofen Li, Xuejun Wang, 2013, American journal of cardiovascular disease.

HDAC Inhibitor L-Carnitine and Proteasome Inhibitor Bortezomib Synergistically Exert Anti-Tumor Activity In Vitro and In Vivo

B. Li, Q. Dou, Jinbao Liu, 2012, PloS one.

Repurposing an antidandruff agent to treating cancer: zinc pyrithione inhibits tumor growth via targeting proteasome-associated deubiquitinases

D. Zang, Jinbao Liu, Xiaofen Li, 2017, Oncotarget.

Physiological levels of ATP negatively regulate proteasome function

Q. Dou, Jinbao Liu, P. Zhou, 2010, Cell Research.

Intracellular ATP Concentration Contributes to the Cytotoxic and Cytoprotective Effects of Adenosine

Jinbao Liu, Xiaofen Li, Hongbiao Huang, 2013, PloS one.

Two clinical drugs deubiquitinase inhibitor auranofin and aldehyde dehydrogenase inhibitor disulfiram trigger synergistic anti-tumor effects in vitro and in vivo

D. Zang, Jinbao Liu, Xiaofen Li, 2015, Oncotarget.

Gambogic acid is a tissue-specific proteasome inhibitor in vitro and in vivo.

Q. Dou, Jinbao Liu, P. Zhou, 2013, Cell reports.

The combination of proteasome inhibitors bortezomib and gambogic acid triggers synergistic cytotoxicity in vitro but not in vivo.

Jinbao Liu, Xiaofen Li, Hongbiao Huang, 2014, Toxicology letters.

Anacardic acid induces cell apoptosis associated with induction of ATF4-dependent endoplasmic reticulum stress.

Jinbao Liu, Xiaofen Li, Hongbiao Huang, 2014, Toxicology letters.

Sanggenon C decreases tumor cell viability associated with proteasome inhibition.

Q. Dou, Jinbao Liu, P. Zhou, 2011, Frontiers in bioscience.

Clinically used antirheumatic agent auranofin is a proteasomal deubiquitinase inhibitor and inhibits tumor growth

Ping Zhou, Wenbin Song, Li Xu, 2014, Oncotarget.

A novel proteasome inhibitor suppresses tumor growth via targeting both 19S proteasome deubiquitinases and 20S proteolytic peptidases

Q. Dou, Jinbao Liu, P. Zhou, 2014, Scientific Reports.

Development of a Chemical Cocktail That Rescues Mouse Brain Demyelination in a Cuprizone-Induced Model

S. C. Schuyler, Hsuan-Pei Lin, Jean Lu, 2022, Cells.

Gambogic acid enhances proteasome inhibitor-induced anticancer activity.

Di Chen, Q. Dou, Jinbao Liu, 2011, Cancer letters.

L-Carnitine Is an Endogenous HDAC Inhibitor Selectively Inhibiting Cancer Cell Growth In Vivo and In Vitro

Bing Li, Wenbin Song, Li Xu, 2012, PloS one.

Platinum-containing compound platinum pyrithione is stronger and safer than cisplatin in cancer therapy

D. Zang, Jinbao Liu, Zhiming He, 2016, Biochemical pharmacology.

A microRNA-mediated decrease in eukaryotic initiation factor 2α promotes cell survival during PS-341 treatment

D. Zang, Jinbao Liu, Xiaofen Li, 2016, Scientific Reports.

A novel nickel complex works as a proteasomal deubiquitinase inhibitor for cancer therapy

D. Zang, Q. Dou, Jinbao Liu, 2016, Oncogene.

Calcium channel blocker verapamil accelerates gambogic acid-induced cytotoxicity via enhancing proteasome inhibition and ROS generation.

Q. Dou, Jinbao Liu, Xiaofen Li, 2014, Toxicology in vitro : an international journal published in association with BIBRA.